Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Neal

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|November 11, 2011
Psychiatric comorbidity and treatment response in patients with tuberous sclerosis complexThomas K Chung, Elizabeth R Lynch, Cheryl J Fiser, et al.
Neurology|November 6, 2016
Long-term treatment of epilepsy with everolimus in tuberous sclerosisDarcy A Krueger, Angus A Wilfong, Maxwell Mays, et al.
BJU International|January 15, 2008
Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004Sabina Hussain, David Gunnell, Jenny Donovan, et al.
Stem Cells (Dayton, Ohio)|May 10, 2022
Krüppel-like Factor 4 Supports the Expansion of Leukemia Stem Cells in MLL-AF9-driven Acute Myeloid LeukemiaAndrew Henry Lewis, Cory Seth Bridges, David Neal Moorshead, et al.
Frontiers in Dementia|December 25, 2025
Online peer support for Young Onset Dementia is a promising resource, but not a panacea: a commentary from the INTERDEM Young Onset Dementia taskforceAysegul Humeyra Kafadar, Esther Vera Loseto-Gerritzen, Christian Bakker, et al.
The New England Journal of Medicine|November 5, 2010
Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosisDarcy A Krueger, Marguerite M Care, Katherine Holland, et al.
The Journal of Urology|January 26, 2018
Value of Intact Prostate Specific Antigen and Human Kallikrein 2 in the 4 Kallikrein Predictive Model: An Individual Patient Data Meta-AnalysisAndrew Vickers, Emily A Vertosick, Daniel D Sjoberg, et al.
Seizure|June 22, 2018
Calcification in cerebral parenchyma affects pharmacoresistant epilepsy in tuberous sclerosisMeng-Na Zhang, Li-Ping Zou, Yang-Yang Wang, et al.
Yearbook of Medical Informatics|June 2, 2022
Overcoming Challenges to Inclusive User-based Testing of Health Information Technology with Vulnerable Older Adults: Recommendations from a Human Factors Engineering Expert InquiryLinda W Peute, Gaby-Anne Wildenbos, Thomas Engelsma, et al.
BMJ Open|June 27, 2015
A pilot randomised controlled trial of personalised care after treatment for prostate cancer (TOPCAT-P): nurse-led holistic-needs assessment and individualised psychoeducational intervention: study protocolMarian Andrei Stanciu, Caroline Morris, Matt Makin, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|November 11, 2011
Psychiatric comorbidity and treatment response in patients with tuberous sclerosis complexThomas K Chung, Elizabeth R Lynch, Cheryl J Fiser, et al.
Neurology|November 6, 2016
Long-term treatment of epilepsy with everolimus in tuberous sclerosisDarcy A Krueger, Angus A Wilfong, Maxwell Mays, et al.
BJU International|January 15, 2008
Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004Sabina Hussain, David Gunnell, Jenny Donovan, et al.
Stem Cells (Dayton, Ohio)|May 10, 2022
Krüppel-like Factor 4 Supports the Expansion of Leukemia Stem Cells in MLL-AF9-driven Acute Myeloid LeukemiaAndrew Henry Lewis, Cory Seth Bridges, David Neal Moorshead, et al.
Frontiers in Dementia|December 25, 2025
Online peer support for Young Onset Dementia is a promising resource, but not a panacea: a commentary from the INTERDEM Young Onset Dementia taskforceAysegul Humeyra Kafadar, Esther Vera Loseto-Gerritzen, Christian Bakker, et al.
The New England Journal of Medicine|November 5, 2010
Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosisDarcy A Krueger, Marguerite M Care, Katherine Holland, et al.
The Journal of Urology|January 26, 2018
Value of Intact Prostate Specific Antigen and Human Kallikrein 2 in the 4 Kallikrein Predictive Model: An Individual Patient Data Meta-AnalysisAndrew Vickers, Emily A Vertosick, Daniel D Sjoberg, et al.
Seizure|June 22, 2018
Calcification in cerebral parenchyma affects pharmacoresistant epilepsy in tuberous sclerosisMeng-Na Zhang, Li-Ping Zou, Yang-Yang Wang, et al.
Yearbook of Medical Informatics|June 2, 2022
Overcoming Challenges to Inclusive User-based Testing of Health Information Technology with Vulnerable Older Adults: Recommendations from a Human Factors Engineering Expert InquiryLinda W Peute, Gaby-Anne Wildenbos, Thomas Engelsma, et al.
BMJ Open|June 27, 2015
A pilot randomised controlled trial of personalised care after treatment for prostate cancer (TOPCAT-P): nurse-led holistic-needs assessment and individualised psychoeducational intervention: study protocolMarian Andrei Stanciu, Caroline Morris, Matt Makin, et al.
Pageof 13